SLR Investment Corp. Announces Quarter Ended March 31, 2021 Financial Results
05/05/21
Net Investment Income Growth
Stable Net Asset Value
100% Performing Portfolio
Declares Quarterly Distribution of
At
As of
The Board declared a second quarter distribution of $0.41 per share payable on July 2, 2021 to stockholders of record as of June 23, 2021. The specific tax characteristics will be reported to stockholders on Form 1099 after the end of the calendar year.
HIGHLIGHTS:
At
Number of portfolio companies: >600 | ||
Net assets: |
||
Net asset value per share: |
||
Net debt-to-equity: 0.82x | ||
Available capital**: |
Comprehensive Investment Portfolio Activity*** for the Quarter Ended
Investments made during the quarter: |
||
Investments prepaid and sold during the quarter: |
Operating Results for the Quarter Ended
Net investment income: |
||
Net investment income per share: |
||
Net realized and unrealized gain: |
||
Net increase in net assets from operations: |
||
Earnings per share: |
* The Comprehensive Investment Portfolio for the quarter ended
** Please see Liquidity and Capital Resources.
*** Comprehensive Portfolio Activity for the quarter ended
“During the first quarter of 2021, SLRC drove a 14% increase in gross investment income and an approximately 4% increase in net investment income per share. Continued pristine credit quality resulted in further improvement in valuations and an increase in net asset value per share,” said
“We are pleased with the performance of
Conference Call and Webcast
The Company will host an earnings conference call and audio webcast at
Comprehensive Investment Portfolio
Investment Activity
During the three months ended
The investment activity of our Comprehensive Investment Portfolio for the quarter ended
Comprehensive Investment Portfolio Activity (1) – Q1 2021 (in millions) |
||||||||||||
Asset Class | Cash Flow Loans |
Asset-based Loans / SLR-CS(2) |
Equipment Financings / SLR-EF(3) |
Life Science Loans |
Total Portfolio Activity |
|||||||
Originations | ||||||||||||
Repayments / Amortization |
||||||||||||
Net Portfolio Activity |
$39.7 | ($67.9) | $1.2 | ($0.3) | $9.6 | ($17.7) |
(1) | Total Portfolio Activity includes gross originations/repayments across each business unit. | |
(2) | Includes SLR-CS’ full portfolio and asset-based loans on the Company’s balance sheet. | |
(3) | Includes SLR-EF’s full portfolio and equipment financings on the Company’s balance sheet. | |
(4) | Gross origination and repayment activity for KBH’s portfolio. | |
Portfolio Composition
Our Comprehensive Investment Portfolio composition by business unit at
Comprehensive Investment Portfolio Composition (at fair value) |
Amount | Weighted Average Asset Yield(5) |
|||
($mm) | % | ||||
Cash Flow Senior Secured Loans | 16.1% | 8.6% | |||
Asset-Based Senior Secured Loans / SLR-CS1) | 21.8% | 10.5% | |||
Equipment Senior Secured Financings / SLR-EF(2) | 15.9% | 10.1% | |||
Life Science Senior Secured Loans | 16.4% | 9.1%(6) | |||
29.1% | 10.0% est(7) | ||||
Total Senior Secured Loans | $2,009.4 | 99.3% | 9.8% | ||
0.7% | |||||
Total Comprehensive Investment Portfolio | $2,023.9 | 100% | |||
Floating Rate Investments(4) | 54.7% | ||||
First Lien Senior Secured Loans | 94.4% | ||||
Second Lien Senior Secured Cash Flow Loans | 2.1% | ||||
Second Lien Senior Secured Asset-Based Loans | 2.8% | ||||
(1) | Includes SLR-CS’ full portfolio and asset-based and lender finance loans on the Company’s balance sheet and excludes the Company’s equity investment in SLR-CS. | |
(2) | Includes SLR-EF’s full portfolio and equipment financings on the Company’s balance sheet and excludes the Company’s equity investments in SLR-EF. | |
(3) | Includes KBH’s full portfolio and excludes the Company’s equity and debt investments in KBH. | |
(4) | Floating rate investments calculated as a percent of the Company’s income-producing Comprehensive Investment Portfolio. The majority of fixed rate loans are associated with SLR-EF and leases associated with KBH. Additionally, SLR-EF and KBH seek to match-fund their fixed rate assets with fixed rate liabilities. | |
(5) | The weighted average asset yield for cash flow, asset-based and life science loans on balance sheet is based on a yield to maturity calculation. The weighted average yield for equipment financing and SLR-CS asset-based loans is calculated based on the expected average life of a loan for each asset class. | |
(6) | Life Science yields exclude the impact of success fees and/or warrants. | |
(7) | Represents expected return on equity during 2021. | |
The Comprehensive Investment Portfolio is diversified across over 600 unique borrowers in over 80 industries and with an average exposure of
At
The weighted average yield at fair value of all income-producing investments in the Comprehensive Portfolio was 9.8% at
Asset Quality
As of
The Company puts its greatest emphasis on risk mitigation and credit performance. On a quarterly basis, or more frequently if deemed necessary, the Company formally rates each portfolio investment on a scale of one to four, with one representing the least amount of risk.
As of
Internal Investment Rating | Investments at Fair Value ($mm) | % of Total Portfolio | ||
1 | 14.9% | |||
2 | 82.3% | |||
3 | 2.8% | |||
4 | 0.0% |
Investment Income Contribution by Business Unit
Business Unit Contribution to Gross Investment Income (1) (in millions) |
|||||||
For the Quarter Ended: |
Cash Flow Lending |
Asset-based Lending / SLR-CS |
Equipment Financing / SLR-EF |
Life Science Lending |
Total | ||
$35.9 | |||||||
% Contribution | 18.8% | 26.2% | 11.3% | 31.5% | 12.2% | 100.0% |
(1) | Investment Income Contribution by Business Unit includes interest income/fees from cash flow loans on balance sheet, income/fees from asset-based loans on balance sheet and distributions from SLR-CS, income/fees from equipment financings and distributions from SLR-EF, distributions from KBH, and income/fees from life science loans. | |
SLR Investment Corp.’s Results of Operations for the Quarter Ended
Investment Income
For the fiscal quarters ended
Expenses
Expenses totaled
Net Investment Income
The Company’s net investment income totaled
Net Realized and Unrealized Gain (Loss)
Net realized and unrealized gains (losses) for the fiscal quarters ended
Net Increase (Decrease) in Net Assets Resulting From Operations
For the quarters ended
Liquidity and Capital Resources
Unsecured Debt
At
At
Leverage
On
Unfunded Commitments
At
Financial Statements and Tables
CONSOLIDATED STATEMENTS OF ASSETS AND LIABILITIES
(in thousands, except share amounts)
March 31, 2021 (unaudited) |
2020 |
||||||
Assets | |||||||
Investments at fair value: | |||||||
Companies less than 5% owned (cost: |
$ | 865,066 | $ | 822,298 | |||
Companies more than 25% owned (cost: |
709,498 | 709,653 | |||||
Cash | 7,762 | 8,779 | |||||
Cash equivalents (cost: |
350,000 | 379,997 | |||||
Dividends receivable | 9,508 | 7,927 | |||||
Interest receivable | 6,875 | 6,478 | |||||
Receivable for investments sold | 956 | 255 | |||||
Prepaid expenses and other assets | 752 | 571 | |||||
Total assets | $ | 1,950,417 | $ | 1,935,958 | |||
Liabilities | |||||||
Debt ( |
$ | 705,845 | $ | 671,451 | |||
Payable for investments and cash equivalents purchased | 350,041 | 380,038 | |||||
Distributions payable | 17,327 | 17,327 | |||||
Management fee payable | 6,810 | 6,535 | |||||
Performance-based incentive fee payable | 3,867 | 792 | |||||
Interest payable | 6,723 | 3,416 | |||||
Administrative services payable | 995 | 1,946 | |||||
Other liabilities and accrued expenses | 2,603 | 2,430 | |||||
Total liabilities | $ | 1,094,211 | $ | 1,083,935 | |||
Net Assets | |||||||
Common stock, par value |
$ | 423 | $ | 423 | |||
Paid-in capital in excess of par | 962,481 | 962,481 | |||||
Accumulated distributable net loss | (106,698 | ) | (110,881 | ) | |||
Total net assets | $ | 856,206 | $ | 852,023 | |||
Net Asset Value Per Share | $ | 20.26 | $ | 20.16 | |||
CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited)
(in thousands, except share amounts)
Three months ended | ||||||||
INVESTMENT INCOME: | ||||||||
Interest: | ||||||||
Companies less than 5% owned | $ | 20,832 | $ | 24,834 | ||||
Companies more than 25% owned | 2,885 | 1,356 | ||||||
Dividends: | ||||||||
Companies less than 5% owned | 133 | 13 | ||||||
Companies more than 25% owned | 9,575 | 6,468 | ||||||
Other income: | ||||||||
Companies less than 5% owned | 2,462 | 228 | ||||||
Companies more than 25% owned | — | 5 | ||||||
Total investment income | 35,887 | 32,904 | ||||||
EXPENSES: | ||||||||
Management fees | $ | 6,810 | $ | 6,269 | ||||
Performance-based incentive fees | 3,867 | 1,480 | ||||||
Interest and other credit facility expenses | 7,229 | 7,040 | ||||||
Administrative services expense | 1,360 | 1,147 | ||||||
Other general and administrative expenses | 1,155 | 1,115 | ||||||
Total expenses | 20,421 | 17,051 | ||||||
Net investment income | $ | 15,466 | $ | 15,853 | ||||
REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS, CASH EQUIVALENTS, DEBT AND UNFUNDED COMMITMENTS: |
||||||||
Net realized gain (loss) on investments and cash equivalents (companies less than 5% owned) |
$ | (366 | ) | $ | 28 | |||
Net change in unrealized gain (loss) on investments, cash equivalents and unfunded commitments and net change in unrealized (gain) loss on debt: | ||||||||
Companies less than 5% owned | 6,046 | (47,415 | ) | |||||
Companies more than 25% owned | 364 | (55,074 | ) | |||||
Debt | — | 11,500 | ||||||
Unfunded commitments | — | (361 | ) | |||||
Net change in unrealized gain (loss) on investments, cash equivalents, debt and unfunded commitments | 6,410 | (91,350 | ) | |||||
Net realized and unrealized gain (loss) on investments, cash equivalents, debt and unfunded commitments | 6,044 | (91,322 | ) | |||||
NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS |
$ | 21,510 | $ | (75,469 | ) | |||
EARNINGS (LOSS) PER SHARE | $ | 0.51 | $ | (1.79 | ) | |||
About
SLR Investment Corp. is a closed-end investment company that has elected to be treated as a business development company under the Investment Company Act of 1940. A specialty finance company with expertise in several niche markets, the Company primarily invests directly and indirectly in leveraged, U. S. middle market companies in the form of cash flow senior secured loans including first lien and second lien debt instruments and asset-based loans including senior secured loans collateralized on a first lien basis primarily by current assets.
Forward-Looking Statements
Statements included herein may constitute “forward-looking statements,” which relate to future events or our future performance or financial condition. These statements are not guarantees of our future performance, financial condition or results and involve a number of risks and uncertainties, including the impact of COVID-19 and related changes in base interest rates and significant market volatility on our business, our portfolio companies and the global economy. Actual results may differ materially from those in the forward-looking statements as a result of a number of factors, including those described from time to time in our filings with
Contact
Investor Relations
(646) 308-8770
Source: SLR Investment Corp.